Comparison of immunohistochemical markers before and after neo-adjuvant chemotherapy in breast cancer and their use as predictor od response

Jovanic I.; Milovanovic Z.; Zivkovic O.; Milijic N. Medic

首页> 外文期刊>Virchows Archiv: an international journal of pathology >Comparison of immunohistochemical markers before and after neo-adjuvant chemotherapy in breast cancer and their use as predictor od response

【24h】

Comparison of immunohistochemical markers before and after neo-adjuvant chemotherapy in breast cancer and their use as predictor od response

机译：乳腺癌新辅助化疗前后免疫组织化学标志物的比较及其作为预测因子OD反应的用途

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Virchows Archiv: an international journal of pathology 》 |2018年第1期| 共1页
作者
Jovanic I.; Milovanovic Z.; Zivkovic O.; Milijic N. Medic;
展开▼
作者单位

Inst Oncol &

Rad Dept Pathol Belgrade Serbia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学微生物学（病原细菌学、病原微生物学） ;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of immunohistochemical markers before and after neo-adjuvant chemotherapy in breast cancer and their use as predictor od response [J] . Jovanic I., Milovanovic Z., Zivkovic O., Virchows Archiv: an international journal of pathology . 2018 ,第Suppla1期

机译：乳腺癌新辅助化疗前后免疫组织化学标志物的比较及其作为预测因子OD反应的用途
2. Immunohistochemical expression of carcinoembryonic antigen-related cell adhesion molecules 5, CEACAM6, and SLC7A5: Do they aid in predicting the response to neo-adjuvant chemotherapy in locally advanced breast cancer? [J] . Anju Bansal, Mukesh Garg, Chintamani Chintamani, Clinical Cancer Investigation Journal . 2014 ,第6期

机译：癌胚抗原相关细胞粘附分子5，CEACAM6和SLC7A5的免疫组织化学表达：它们是否有助于预测局部晚期乳腺癌对新辅助化疗的反应？
3. 552 POSTER Identification of predictive markers for tumour response to neo-adjuvant chemotherapy (NCT) treatment for locally-advanced breast cancer (LABC) [J] . V.Ganju, A.Strickland, S.Hart, European Journal of Cancer Supplements . 2007 ,第4期

机译：552海报鉴定局部晚期乳腺癌（LABC）对新辅助化疗（NCT）治疗肿瘤反应的预测标志物
4. Determining the importance of parameters extracted from multi-parametric MRI in the early prediction of the response to neo-adjuvant chemotherapy in breast cancer [C] . Amirhessam Tahmassebi, Katja Pinker-Domenig, Georg Wengert, SPIE Medical Imaging Conference . 2018

机译：确定从多参数MRI提取的参数在乳腺癌新辅助化疗反应的早期预测中的重要性
5. Using Preoperative Mri-guided Biopsies to Predict Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer [D] . Kim, Jiyoon. 2019

机译：在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
6. Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases [O] . Y Horimoto, A Arakawa, N Harada-Shoji, 2015

机译：低的FOXA1表达预示着对新辅助化疗的良好反应从而使管腔HER2阴性乳腺癌病例具有良好的预后
7. Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases [O] . Y Horimoto, A Arakawa, N Harada-Shoji, 2014

机译：低FoxA1表达预测对新辅助化疗的良好反应，导致腔2阴性乳腺癌病例的良好结果
8. Characterization of Fatty Acid Synthase (FAS) as a Predictive Marker of Breast Cancer Sensitivity to Chemotherapy. [R] . Menendez, J. A. 2005

机译：表征脂肪酸合成酶（Fas）作为乳腺癌化疗敏感性的预测标志物。

Comparison of immunohistochemical markers before and after neo-adjuvant chemotherapy in breast cancer and their use as predictor od response

著录项

相似文献

相关主题

期刊订阅